To examine longer-term associations of semaglutide with AUD, the outcome incident and recurrent diagnosis of AUD in patients with T2DM was further followed for 2-year, 3-year starting after the index event
Yet, conditions like leaky gut, irritable bowel syndrome (IBS), and chronic inflammation disrupt this delicate balance, leading to various health concerns
Shed been struggling with weight gain ever since getting diagnosed with polycystic ovary syndrome as a teenager
Resmetirom, as an oral medication, is a promising solution as it is safe and well-tolerated for long-term use and provides more convenience and accessibility for patients who may be afraid of injections
The number that stands out is the 643% jump among people without diabetes
Using the available post treatment weights at varying time points per patient, the mixed effects analysis enabled us to look at the data more broadly as opposed to the categorization approach undertaken thus far